Uploaded October 2021 | Updated November 2026, 6 days ago
Unlike other organs, the heart greatly loses its regenerative potential to repair damaged tissue shortly after birth. Instead, damage is patched up with fibrotic scars and this can reduce the functional capabilities of the heart.
Other tissues typically repair damage and replace lost cells by having stem cells - cells that are undifferentiated, have the potential to self-renew but also to differentiate into specialised cells. Nobel Prize winning work has shown that you can reprogram specialised cells back to stem cells if they express "Yamanaka factors" - OCT4, SOX-2, KLF-4, c-MYC. This process is known as cellular reprogramming and is hoped to be a great tool for regenerative therapeutics.
Is it possible for the heart cells (cardiomyocytes)? Well, this was tested in mice in a recent paper, where they show that partial reprogramming was able to get the cardiomyocytes to divide and reduce the amount of heart function lost after myocardial infarction. Complete reprogramming caused the cells to instead lose their identity and form neoplasms.
So, what this work demonstrates is that there is potential to rejuvenate the heart, BUT, the expression duration and dose of the factors need to be carefully controlled to avoid cancerous growths. This will make applying this strategy to humans challenging, but who doesn't love a challenge?
Find me on Twitter - twitter.com/EleanorSheekey
I have Patreon - patreon.com/TheSheekeyScienceShow
TIMESTAMPS:
Intro - 00:00
Heart & stem cells - 01:00
Cellular reprogramming - 02:20
Partial reprogramming - 03:30
Rejuvenate the heart? - 04:30
A safe approach - 09:00
REFERENCES:
REVERSIBLE REPROGRAMMING OF CARDIOMYOCYTES TO A FETAL STATE DRIVES HEART REGENERATION IN MICE - science.org/doi/10.1126/science.abg5159
Reversing aging for heart repair - science.org/doi/10.1126/science.abl8679
Icons in intro; "freepik.com/free-photos-vectors/background"Background vector created by freepik - freepik.com
Unlike other organs, the heart greatly loses its regenerative potential to repair damaged tissue shortly after birth. Instead, damage is patched up with fibrotic scars and this can reduce the functional capabilities of the heart.
Other tissues typically repair damage and replace lost cells by having stem cells - cells that are undifferentiated, have the potential to self-renew but also to differentiate into specialised cells. Nobel Prize winning work has shown that you can reprogram specialised cells back to stem cells if they express "Yamanaka factors" - OCT4, SOX-2, KLF-4, c-MYC. This process is known as cellular reprogramming and is hoped to be a great tool for regenerative therapeutics.
Is it possible for the heart cells (cardiomyocytes)? Well, this was tested in mice in a recent paper, where they show that partial reprogramming was able to get the cardiomyocytes to divide and reduce the amount of heart function lost after myocardial infarction. Complete reprogramming caused the cells to instead lose their identity and form neoplasms.
So, what this work demonstrates is that there is potential to rejuvenate the heart, BUT, the expression duration and dose of the factors need to be carefully controlled to avoid cancerous growths. This will make applying this strategy to humans challenging, but who doesn't love a challenge?
Find me on Twitter - twitter.com/EleanorSheekey
I have Patreon - patreon.com/TheSheekeyScienceShow
TIMESTAMPS:
Intro - 00:00
Heart & stem cells - 01:00
Cellular reprogramming - 02:20
Partial reprogramming - 03:30
Rejuvenate the heart? - 04:30
A safe approach - 09:00
REFERENCES:
REVERSIBLE REPROGRAMMING OF CARDIOMYOCYTES TO A FETAL STATE DRIVES HEART REGENERATION IN MICE - science.org/doi/10.1126/science.abg5159
Reversing aging for heart repair - science.org/doi/10.1126/science.abl8679
Icons in intro; "freepik.com/free-photos-vectors/background"Background vector created by freepik - freepik.com






![the 3 levels of aging therapeutics
Why do so many anti-aging drugs work in mice but fail in humans? It turns out, we might be aging in fundamentally different ways. A new minimal model from physicists Peter Fedichev and Jan Gruber suggests that aging isnt a chaotic mess of billions of problems, but a process governed by just three macroscopic variables.
In this video, I break down their paper to explain why current Level 1 interventions (like senolytics and cellular reprogramming) might only improve healthspan, not maximum lifespan. Well explore the difference between stable species (humans) and unstable ones (mice), and reveal the physics-based roadmap—Level 2 and Level 3—required to actually extend the human lifespan limit beyond 120 years.
Find me on Twitter - https://twitter.com/EleanorSheekey
Support the channel
through PayPal - https://paypal.me/sheekeyscience?country.x=GB&locale.x=en_GB
through Patreon - https://www.patreon.com/TheSheekeyScienceShow
TIMESTAMPS
0:00 – Why 300 aging theories might be wrong (The Physics of Universality)
3:45 – The 3 variables that control your lifespan
7:12 – Why mice are biologically broken compared to humans
9:58 – The 3 Levels of Intervention: Why reprogramming isnt enough (yet)
13:20 – The only way to actually break the 120-year limit
REFERENCES
Fedichev, P. & Gruber, J. (2024). A Minimal Model Explains Aging Regimes and Guides Intervention Strategies. bioRxiv. [Preprint]
Pyrkov, T. V., et al. (2021). Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts ultimate limit of human lifespan. Nature Communications, 12, 2765.
Avchaciov, K., et al. (2022). Unsupervised learning of aging principles from longitudinal data. Nature Communications, 13, 6529.
Perevoshchikova, K. & Fedichev, P. O. (2024). Differential Responses of Dynamic and Entropic Aging Factors to Longevity Interventions. bioRxiv.
Tarkhov, A. E., et al. (2024). Universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories. AgingBio, 2, 1–16.
Tong, H., et al. (2024). Quantifying the stochastic component of epigenetic aging. Nature Aging, 4, 886–897.
Meyer, D. H. & Schumacher, B. (2024). Biologically informative or merely random? The stochastic nature of epigenetic clocks. Nature Aging, 4, 871–885.
Sinclair, D. A. & Guarente, L. (1997). Extrachromosomal rDNA circles—a cause of aging in yeast. Cell, 91(7), 1033–1042.
Medvedev, Z. A. (1990). An attempt at a rational classification of theories of ageing. Biological Reviews, 65(3), 375–398.
Please note that The Sheekey Science Show is distinct from Eleanor Sheekeys teaching and research roles. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Sheekey Science Show and guests assume no liability for the application of the information discussed.
Icons in intro; https://www.freepik.com/free-photos-vectors/backgroundBackground vector created by freepik - www.freepik.com the 3 levels of aging therapeutics](https://i.ytimg.com/vi/c-_Pdp5IIvw/mqdefault.jpg)



